¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Cancer Drug Deliv"¿¡ ´ëÇÑ KI ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
drug
¾à, ¾à¹°, ¾àÁ¦
drug abuse
¾à¹°³²¿ë
narcotic drug
¸¶¾à
tuberculostatic drug
Ç×°áÇÙ¾à
alveolar cancer
Æ÷»ó¾Ï
breast cancer
À¯¹æ¾Ï
cancer
¾Ï
cancer in situ
»óÇdz»¾Ï, ÀνÃÅõ¾Ï
early gastric cancer
Á¶±âÀ§¾Ï
mammary cancer
À¯¾Ï
ovarian cancer
³¼Ò¾Ï
polypoid cancer
Æú¸³¾ç¾Ï
primary cancer
¿ø¹ß¾Ï
radiation induced cancer
¹æ»ç¼±À¯¹ß¾Ï
skin cancer
ÇǺξÏ
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½